Teleflex (TFX) Akcija Kursas
Teleflex Kursas
Teleflex pajamos traukėsi 1,5 % per metus per pastaruosius 19 metus iki 1,99 mlrd. USD. Pelnas akcijai mažėjo 4,6 % per metus per pastaruosius 18 metus. Teleflex grynoji marža dabar yra −45,4 %, sumažėjo nuo 17,3 % prieš kelerius metus. Teleflex šiuo metu siūlo apie 1,10 % dividendo pajamingumą. Dividendas augo 1,1 % per metus per pastaruosius 19 metus. Analitikų tikslinės kainos mediana yra 156,50 USD, t. y. virš dabartinę kainą 26,5 %. Iš 19 analitikų 8 rekomenduoja pirkti — bendras konsensusas yra Laikyti.
Teleflex akcijos kaina
Teleflex akcija ir akcijų analizė
Dažnai užduodami klausimai apie Teleflex akciją
Teleflex Inc is a leading global provider of medical technologies designed to enhance the health and well-being of patients. With a diverse product portfolio, the company specializes in the development, manufacturing, and distribution of innovative medical devices for a wide range of applications. Teleflex focuses on delivering high-quality solutions in critical care, surgical care, urology, and respiratory care, among others. By leveraging its expertise and strong market presence, Teleflex continuously aims to improve patient outcomes, increase healthcare efficiency, and advance medical innovation.
Teleflex Inc is primarily active in a variety of industries. As a global provider of medical technology products, the company focuses on healthcare, providing innovative solutions in the areas of surgical and diagnostic devices, anesthesia, and critical care. Teleflex Inc also has a presence in the aerospace industry, supplying specialized control systems and components for aircraft and helicopters. With its diverse portfolio, Teleflex Inc continues to make significant contributions in these sectors, driving advancements and improving patient outcomes in healthcare, while delivering reliable and efficient solutions in the aerospace industry.
The main competitors of Teleflex Inc in the market include Johnson & Johnson, Becton, Dickinson and Company, Medtronic plc, and Smiths Medical.
Teleflex Inc is a renowned company specializing in medical technology. Established in 1943, Teleflex has a rich history rooted in innovation and industry leadership. With headquarters in Wayne, Pennsylvania, the company has expanded globally, offering a diverse portfolio of medical devices that enhance patient care and improve clinical outcomes. Teleflex's dedication to research and development has led to breakthrough solutions in respiratory care, surgical instruments, urology, vascular access, and more. By combining cutting-edge technology with a commitment to quality, Teleflex continues to shape the healthcare industry, providing healthcare professionals with the tools they need to deliver superior patient care.
Teleflex Inc has achieved several significant milestones throughout its history. The company expanded its product portfolio by acquiring Arrow International in 2007, a leading manufacturer of critical care products. In 2011, Teleflex successfully launched the MANTA Vascular Closure Device, revolutionizing the way vascular access sites are closed after procedures. Additionally, the company received FDA clearance for the Teleflex UroLift System in 2013, providing a minimally invasive solution for enlarged prostate patients. In recent years, Teleflex also made significant advancements in its vascular access product line, including the introduction of the ARROW PICC with Chlorag+ard Technology. These achievements highlight Teleflex's continuous commitment to innovation and improving patient outcomes.
Teleflex Inc is primarily present in various countries and regions worldwide. The company has a strong global presence, with operations in North America, Europe, Asia Pacific, and Latin America. Teleflex serves customers and healthcare markets in over 150 countries, providing innovative solutions in medical technology and consumer healthcare. With its diverse portfolio of products and services, Teleflex Inc has established itself as a trusted provider in the medical device industry.
Teleflex Inc represents a set of core values and a corporate philosophy that guide its operations. With a focus on innovation and excellence, the company strives to deliver high-quality medical technology solutions to enhance patient outcomes. Teleflex is committed to providing world-class customer service, ensuring the best user experience for healthcare professionals and patients. With a dedication to integrity, teamwork, and continuous improvement, Teleflex values collaboration, transparency, and ethical conduct in all aspects of its business. By prioritizing customer needs and embracing a culture of innovation, Teleflex aims to make a positive impact in the healthcare industry.
Analitikai šiuo metu nustato vidutinę Teleflex akcijos tikslinę kainą 153,88 USD (mediana: 156,50 USD), t. y. +24,4 % palyginti su paskutine kaina. Konsensusas pagrįstas 19 analitikų reitingais.
19 analitikai šiuo metu vertina Teleflex akciją: 8 rekomenduoja pirkti, 11 laikyti ir 0 parduoti. 2026 m. analitikai tikisi, kad Teleflex gaus 2,27 mlrd. USD pajamų ir 7,67 USD pelno akcijai.
Pagal dabartinį kursą Teleflex akcija kainuoja 110,38 EUR (123,69 USD).
Teleflex akcija (TFX) kotiruojama 6 biržose, įskaitant: NYSE (TFX), SIX (Zürich) (TBH.SW), XETRA (TBH.DE), Frankfurt (TBH.F), München (TBH.MU), Düsseldorf (TBH.DU).
Teleflex Inc. is an American company specializing in the manufacturing and selling of medical devices and instruments. It was founded in 1943 and has become a leading provider of medical products. The company divides its business into three main segments: Medical Devices, Anesthesia, and Interventional Medicine. Each segment offers a wide range of products tailored to the specific needs of the healthcare industry. The Medical Devices segment focuses on catheters, leads, drains, and other surgical instruments, while also offering specialized products for cardiology, oncology, and neurology. The Anesthesia segment specializes in products used in anesthesia applications, such as ventilation support devices and block needles. The Interventional Medicine segment focuses on treating and preventing vascular diseases with products like vascular access devices and balloon catheters used in minimally invasive procedures. This segment is the fastest-growing for Teleflex due to increasing demand for minimally invasive treatment methods. Teleflex has built a portfolio of over 30,000 products through acquisitions and internal innovations. Effective management, partnerships with doctors and hospitals, and participation in industry events ensure the company's growth and expansion. In summary, Teleflex Inc. is a company with a wide range of medical products used in various sectors of the healthcare industry. With a global presence and diverse product portfolio, the company can respond to changing customer desires and needs. Through continuous innovation, research, and development, Teleflex aims to revolutionize the healthcare industry and achieve higher levels of effectiveness and efficiency.
tikėtina pelnas Teleflex yra 2,27 mlrd. USD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas Teleflex yra 339,29 mln. USD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Teleflex šiuo metu yra 16,13. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Teleflex akcijos vertę.
Kainų ir pardavimų santykis (KUV) Teleflex šiuo metu yra 2,41. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Teleflex akcijos įvertinimo metrika.
Eulerpool kokybės balas Teleflex yra 0/10.
Teleflex ISIN yra US8793691069. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Teleflex WKN yra 855853. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Teleflex prekybos žymė yra TFX. Ši biržos žymė naudojama Teleflex akcijoms prekiauti biržoje.
Teleflex akcija
Teleflex Pagrindiniai konkurentai
Teleflex Biržos simbolis
Teleflex FIGI
Visos Teleflex pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Teleflex akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Teleflex. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: